- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6858 - Allele-specific amplification
Patent holdings for IPC class C12Q 1/6858
Total number of patents in this class: 1006
10-year publication summary
|
39
|
45
|
71
|
90
|
87
|
94
|
103
|
128
|
100
|
67
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Life Technologies Corporation | 3346 |
37 |
| Exact Sciences Corporation | 306 |
16 |
| Roche Molecular Systems, Inc. | 933 |
16 |
| F. Hoffmann-La Roche AG | 7933 |
13 |
| Celera Corporation | 72 |
13 |
| Agena BioScience, Inc. | 57 |
12 |
| Bio-Rad Laboratories, Inc. | 1619 |
12 |
| Dana-Farber Cancer Institute, Inc. | 2623 |
12 |
| Prognosys Biosciences, Inc. | 104 |
12 |
| William Marsh Rice University | 1045 |
11 |
| Pioneer Hi-Bred International, Inc. | 6770 |
10 |
| Integrated DNA Technologies, Inc. | 287 |
10 |
| Nucleix, Ltd. | 61 |
10 |
| Rutgers, The State University of New Jersey | 1933 |
10 |
| The Johns Hopkins University | 5751 |
9 |
| Natera, Inc. | 329 |
9 |
| Quest Diagnostics Investments LLC | 419 |
9 |
| Pacific Biosciences of California, Inc. | 757 |
8 |
| Seegene, Inc. | 429 |
8 |
| Accuragen Holdings Limited | 52 |
8 |
| Other owners | 761 |